Epstein Rosenblum Maoz (ERM) ‘excels in handling complex, high-stakes cross-border M&A deals, with unmatched regulatory expertise’. Its work encompasses advice on clinical trials, IP, venture capital funding, and much more. The practice is led by corporate and VC specialist Ron Abelski, who is ’a trusted advisor and an excellent negotiator’, and cross-border financing expert Simon Marks, who ‘solves complicated issues’. Abelski recently acted for a leading global provider of products and services for patients with chronic kidney failure in the negotiation of commercial contracts, and the import and distribution of pharmaceuticals, medical devices, and disposables in Israel.
Testimonials
Collated independently by Legal 500 research team.
‘This team is professional. They specialise in hi-tech companies. They respond quickly and supply a very good service. They understand the challenges of small start-up companies.’
‘Simon Marks solves complicated issues and mentors his team. Senior associate Itamar Lev Eldar prepares the documents and the contracts. Very meticulous. Associate Noam Zimerman - Very creative and responsive.’
‘A very devoted team, with deep understanding and out of the box thinking. It is a team of dealmakers.’
‘I have worked with Roni Abelski, who is very knowledgeable, a trusted advisor to his client and an excellent negotiator. I have also worked with Michal Molcho, a brilliant associate, who leads a deal from A to Z in a most impressive way. Michal is sharp, targeted and leads her client to the ultimate outcome.’
‘High professionalism, very swift and detailed answers to even complex legal questions. Very good availability.’
‘Ron Abelski has a very skilled approach to legal situations and he can immediately translate into legal language. His advice is not only legal but also reflects strategy and economic aspects.’
‘The team at ERM have deep industry knowledge in healthcare services, which helps a lot in deal structuring and risk assessment. The team's flat hierarchy and open communication foster innovative problem-solving and rapid response to client needs.’
‘We work closely with senior partner, Ron Abelski. He is a great negotiator, very strategic and he and his team closed for us multiple deals during the COVID-19 pandemic and during other crisis, through creative restructuring and renegotiation.’
Key clients
- Fresenius Medical Care Israel
- Fresenius Medical Care P.B.
- Pitango Venture Capital
- 3d Innotech
- Angel Investors
- Neoterra Holdings Ltd
- Aluma Resilience
- QR Genetics Ltd
- Selfit Medical Ltd
- MDT – Micro Diamond Technologies
- On Clinic Advanced Medical Institutes
- Bioxtreme Ltd.
- IQVIA
- Happiness Capital
- GHF
- BVI Medical
- Atvisor AI
- Hisense Ltd.
- PillTracker Ltd.
- Anacure Medical
- Alive HealthTech Fund
- Novolog
- Tethys Equity
Work highlights
- Advising Fresenius Medical Care Israel on all its ongoing Israeli commercial and regulatory matters, including agreements with all of Israel’s HMOs.
- Advising GHF on all of its ongoing matters, including its current investment round, corporate matters and clinical trials as well as the drafting and negotiations of a 20-year complex license agreement with Columbia University, Ramot and Hadasit Medical Research Services & Development for the commercialisation of certain IP developed by the licensors.
- Advising Hisense Ltd on its ongoing commercial agreements, as well as its compliance and privacy regulation work, in connection with the company’s smart baby-monitoring product suite.
Practice head
The lawyer(s) leading their teams.
Ron Abelski, Simon Marks